ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN: 120 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
120
Total FAERS Reports
8 (6.7%)
Deaths Reported
66
Hospitalizations
120
As Primary/Secondary Suspect
24
Life-Threatening
1
Disabilities
First Report: 20090302 · Latest Report: 20250626
What Are the Most Common ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN Side Effects?
#1 Most Reported
Pruritus
17 reports (14.2%)
#2 Most Reported
Hepatitis fulminant
15 reports (12.5%)
#3 Most Reported
Rash pruritic
12 reports (10.0%)
All ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Pruritus | 17 | 14.2% | 0 | 13 |
| Hepatitis fulminant | 15 | 12.5% | 3 | 12 |
| Hepatic failure | 12 | 10.0% | 1 | 11 |
| Rash pruritic | 12 | 10.0% | 0 | 11 |
| Drug reaction with eosinophilia and systemic symptoms | 11 | 9.2% | 0 | 8 |
| Pyrexia | 11 | 9.2% | 0 | 7 |
| Hypertransaminasaemia | 10 | 8.3% | 0 | 7 |
| Drug-induced liver injury | 9 | 7.5% | 1 | 3 |
| Nausea | 9 | 7.5% | 0 | 4 |
| Hepatitis | 8 | 6.7% | 0 | 8 |
| Acute kidney injury | 7 | 5.8% | 1 | 6 |
| Cholestasis | 7 | 5.8% | 0 | 7 |
| Erythema | 7 | 5.8% | 0 | 3 |
| Alanine aminotransferase increased | 6 | 5.0% | 0 | 0 |
| Anaemia | 6 | 5.0% | 0 | 3 |
| Hyperbilirubinaemia | 6 | 5.0% | 3 | 3 |
| Vomiting | 6 | 5.0% | 0 | 3 |
| Aspartate aminotransferase increased | 5 | 4.2% | 0 | 0 |
| Coagulopathy | 5 | 4.2% | 0 | 5 |
| Eosinophilia | 5 | 4.2% | 0 | 2 |
Who Reports ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN Side Effects? Age & Gender Data
Gender: 49.6% female, 50.4% male. Average age: 47.5 years. Most reports from: ES. View detailed demographics →
Is ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2009 | 8 | 0 | 1 |
| 2010 | 3 | 0 | 1 |
| 2013 | 4 | 2 | 3 |
| 2014 | 9 | 0 | 4 |
| 2015 | 4 | 0 | 2 |
| 2016 | 6 | 0 | 4 |
| 2017 | 9 | 0 | 7 |
| 2018 | 13 | 0 | 9 |
| 2019 | 6 | 0 | 1 |
| 2020 | 15 | 0 | 12 |
| 2021 | 5 | 0 | 3 |
| 2022 | 2 | 0 | 1 |
| 2023 | 7 | 1 | 5 |
| 2024 | 4 | 3 | 1 |
| 2025 | 1 | 0 | 1 |
What Is ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN Used For?
| Indication | Reports |
|---|---|
| Tuberculosis | 49 |
| Pulmonary tuberculosis | 23 |
| Disseminated tuberculosis | 12 |
| Lymph node tuberculosis | 11 |
| Product used for unknown indication | 10 |
ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN vs Alternatives: Which Is Safer?
ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN vs ETHANOL
ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN vs ETHINYL ESTRADIOL
ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN vs ETHINYL ESTRADIOL\ETONOGESTREL
ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN vs ETHINYL ESTRADIOL\FERROUS\NORETHINDRONE
ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN vs ETHINYL ESTRADIOL\GESTODENE
ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN vs ETHINYL ESTRADIOL\LEVONORGESTREL
ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN vs ETHINYL ESTRADIOL\NORELGESTROMIN
ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN vs ETHINYL ESTRADIOL\NORETHINDRONE
ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN vs ETHINYL ESTRADIOL\NORGESTIMATE
ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN vs ETHINYL ESTRADIOL\NORGESTREL
Official FDA Label for ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN
Official prescribing information from the FDA-approved drug label.